The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective study to measure the impact of MMprofiler on treatment intention in newly diagnosed multiple myeloma patients (PROMMIS).
 
Parameswaran Hari
Honoraria - Amgen; Celgene; Juno Therapeutics; Novartis; Sanofi; Spectrum Pharmaceuticals
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Kite, a Gilead company; Sanofi; Spectrum Pharmaceuticals; Takeda
Research Funding - Celgene (Inst); Millennium (Inst); Onyx (Inst); Spectrum Pharmaceuticals (Inst)
 
Suzanne Lentzsch
Stock and Other Ownership Interests - Caelum Biosciences
Consulting or Advisory Role - Bristol-Myers Squibb; Caelum Biosciences; Janssen; Novartis
Patents, Royalties, Other Intellectual Property - Sanofi
Travel, Accommodations, Expenses - Janssen
Other Relationship - Sorrento Therapeutics
 
David Samuel DiCapua Siegel
Stock and Other Ownership Interests - Celularity
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Karyopharm Therapeutics; Merck; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Takeda
Research Funding - Celgene (Inst)
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Seagen; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen Oncology; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; Janssen Oncology; Pharmacyclics; Sanofi; Seagen
 
Binod Dhakal
Honoraria - Celgene
Consulting or Advisory Role - Amgen; Takeda
Research Funding - Amgen (Inst)
 
Adriana C. Rossi
Honoraria - Celgene; Janssen
Consulting or Advisory Role - Celgene; Janssen; Thrasos Therapeutics
Research Funding - Amgen (Inst); Celgene (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Celgene
 
Cara Ann Rosenbaum
No Relationships to Disclose
 
Siyang Leng
No Relationships to Disclose
 
Divaya Bhutani
No Relationships to Disclose
 
Noa Biran
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Celgene; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Karyopharm Therapeutics (Inst); Merck (Inst)
 
David H. Vesole
Stock and Other Ownership Interests - Abbvie; Amgen; Biogen; Gilead Sciences; Johnson & Johnson; Lilly; Novartis
Honoraria - Amgen; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen Oncology; Takeda
 
Manisha Bhutani
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Takeda
Research Funding - Prothena (Inst)
 
Lisette Stork-Sloots
Consulting or Advisory Role - Agendia; Celgene; Skyline Diagnostics
 
Femke De Snoo
Consulting or Advisory Role - Agendia; Skyline Diagnostics
 
Belinda C. Dumee
Employment - Skyline Diagnostics
 
Martin Van Vliet
Employment - Skyline Diagnostics
 
Ruben Niesvizky
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda